In 1984 was created Centene, which is appeared as Corporate Investor. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the St Louis.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Centene, startups are often financed by Skyline Ventures, SV Health Investors, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are WuXi Healthcare Ventures, Waterline Ventures, Vida Ventures. In the next rounds fund is usually obtained by National Institutes of Health, National Institute on Aging.
The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline Quartet, RxAdvance, RubiconMD Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Pharmaceutical, mHealth.
This Centene works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2018. The increased amount of exits for fund were in 2019. The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. The fund is constantly included in 2-6 deals per year. Deals in the range of 50 - 100 millions dollars are the general things for fund.
Related Funds
Fund Name | Location |
Attia Ventures | Germany, Hamburg |
Beijing Youqing Yutong Yiliao Touzi Youxian Gongsi | Beijing, Beijing, China |
Chesapeake Partners Management | Bethesda, Maryland, United States |
Denshi-koen | Japan, Tokyo |
eGuardian | Central Region, Singapore, Singapore |
Huifu Payment | China, Shanghai, Xuhui |
Innogy Venture Capital | Essen, Germany, Nordrhein-Westfalen |
Irontek | Beloit, United States, Wisconsin |
Postmedia Network | Canada, Ontario, Toronto |
Proioxis Ventures Fund | - |
Rizal Microbank | - |
StartingPoint Venture Partners | New York, New York, United States |
Steadfast Venture Capital | New York, New York, United States |
Tin Men Capital | Central Region, Singapore, Singapore |
Tokyu Agency | Japan, Kanagawa Prefecture, Kawasaki |
University of Pennsylvania Graduate School of Education (GSE) | Pennsylvania, Philadelphia, United States |
Verstra Ventures | Canada, Ontario, Toronto |
Virage Logic Corporation | California, Fremont, United States |
Wingate Ventures | Israel, Tel Aviv, Tel Aviv District |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Main Street Health | $315M | 08 Oct 2023 | Nashville, Tennessee, United States | ||
Hazel Health | $51M | 27 Oct 2022 | San Francisco, California, United States | ||
Diameter Health | $18M | 17 Dec 2020 | Connecticut, United States | ||
Hazel Health | $33M | 01 Sep 2020 | San Francisco, California, United States | ||
RubiconMD | $13M | 19 Apr 2018 | New York, New York, United States | ||
IDEAYA Biosciences | $94M | 15 Mar 2018 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Main Street Health | $315M | 08 Oct 2023 | Nashville, Tennessee, United States | ||
Hazel Health | $51M | 27 Oct 2022 | San Francisco, California, United States | ||
Diameter Health | $18M | 17 Dec 2020 | Connecticut, United States | ||
Hazel Health | $33M | 01 Sep 2020 | San Francisco, California, United States | ||
RubiconMD | $13M | 19 Apr 2018 | New York, New York, United States | ||
IDEAYA Biosciences | $94M | 15 Mar 2018 | South San Francisco, California, United States |